Current Report Filing (8-k)
July 31 2014 - 4:34PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): July 31, 2014
|
|
Zoetis Inc. |
(Exact name of registrant as specified in its charter) |
|
| | | | |
Delaware | | 001-35797 | | 46-0696167 |
(State or other jurisdiction | | (Commission File | | (I.R.S. Employer |
of incorporation) | | Number) | | Identification No.) |
|
| | |
100 Campus Drive, Florham Park, NJ | | 07932 |
(Address of principal executive offices) | | (Zip Code) |
|
|
(973) 822-7000 |
(Registrant's telephone number, including area code) |
|
|
Not Applicable |
(Former Name or Former Address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
| |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01. Regulation FD Disclosure.
On July 31, 2014, the Zoetis Board of Directors declared a third quarter dividend, payable to holders of record of the Company's common stock on August 20, 2014, of $0.072 per share payable on September 2, 2014.
Item 9.01. Financial Statements and Exhibits.
99.1 Press Release issued on July 31, 2014.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| | |
ZOETIS INC. |
| |
By: | | /s/ Heidi C. Chen |
Name: | | Heidi C. Chen |
Title: | | Executive Vice President, |
| | General Counsel and Corporate Secretary |
Dated: July 31, 2014
INDEX OF EXHIBITS
|
| | |
|
Exhibit | | |
Number | | Description |
| | |
99.1 | | Press Release issued on July 31, 2014. |
Exhibit 99.1
For immediate release:
July 31, 2014
|
| | |
Media Contacts: | | Investor Contacts: |
Bill Price | | John O'Connor |
1-973-443-2742 (o) | | 1-973-822-7088 (o) |
william.price@zoetis.com | | |
| | |
Kristen Seely
| |
|
1-973-443-2777 (o)
| |
|
kristen.seely@zoetis.com
| | |
Zoetis Declares Third Quarter 2014 Dividend
FLORHAM PARK, N.J. - July 31, 2014 - The Board of Directors of Zoetis Inc. (NYSE:ZTS) declared a third quarter dividend payable to holders of the company’s common stock of $0.072 per share. The dividend is to be paid on Tuesday, Sept. 2, 2014, to holders of record on Wednesday, Aug. 20, 2014.
About Zoetis
Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2013, the company generated annual revenue of $4.6 billion. With approximately 9,800 employees worldwide at the beginning of 2014, Zoetis has a local presence in approximately 70 countries, including 28 manufacturing facilities in 11 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries. For more information, visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking Statements: This press release may contain forward-looking statements, which reflect Zoetis's current views with respect to business plans or prospects, future operating or financial performance, expectations regarding indebtedness, future use of cash and dividend payments, and other future events. These statements are not guarantees of future performance
or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2013, including in the sections thereof captioned “Forward-Looking Information and Factors That May Affect Future Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. These filings and subsequent filings are available online at www.sec.gov, www.zoetis.com, or on request from Zoetis.
# # #
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jul 2023 to Jul 2024
